Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency
Abstract Background Ornithine transcarbamylase deficiency (OTCD) is most common among urea cycle disorders (UCDs), defined by defects in enzymes associated with ureagenesis. Corticosteroid administration to UCD patients, including OTCD patients, is suggested to be avoided, as it may induce life-thre...
Main Authors: | Koji Imoto, Masatake Tanaka, Takeshi Goya, Tomomi Aoyagi, Motoi Takahashi, Miho Kurokawa, Shigeki Tashiro, Masaki Kato, Motoyuki Kohjima, Yoshihiro Ogawa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-03-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-022-02213-0 |
Similar Items
-
Antepartum Ornithine Transcarbamylase Deficiency
by: Hitoshi Nakajima, et al.
Published: (2014-11-01) -
Effect of Ornithine Transcarbamylase (OTC) Deficiency on Pregnancy and Puerperium
by: Rastislav Sysák, et al.
Published: (2022-02-01) -
Clinical and molecular characteristics of 69 Chinese patients with ornithine transcarbamylase deficiency
by: Deyun Lu, et al.
Published: (2020-12-01) -
Variable disease manifestations and metabolic management within a single family affected by ornithine transcarbamylase deficiency
by: Joshua Baker, et al.
Published: (2022-12-01) -
Considerations for prenatal and postpartum management of a female patient with ornithine transcarbamylase deficiency
by: Annette Feigenbaum, et al.
Published: (2022-12-01)